Drugs / pPJV2012
last change Jan 2007 re-read 3 minutes ago

pPJV2012

Developed for
influenza · herpes simplex type 2 infectious disease
Investigated by
PowderMed

Trials 3

2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00349037 Sep 2006 → Jan 2007 influenza PowderMed Completed No outcome recorded
Phase 1 NCT00347529 Aug 2006 → Jan 2007 influenza PowderMed Completed No outcome recorded
Phase 1 NCT00310271 Apr → Dec 2006 herpes simplex type 2 infectious disease PowderMed Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 3 sources stand behind the page.

FieldValueCited text
Known as pPJV2012 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00310271 ↗
2

NCT00347529 ↗

NCT00349037 ↗

Route Other “administered by Particle Mediated Epidermal Delivery (PMED)” NCT00310271 ↗